The fact that in this study patients with pre-existing moderate or more severe disability represented a very small part of the entire sample of AIS patients receiving IVT (2.4%) confirms that stroke physicians infrequently use recombinant tissue plasminogen activator (rt-PA) in these subjects [14]. Here, PLAT is linked to androgen insensitivity syndrome.